Decreased sensitivity of 18F-fluorodeoxyglucose imaging in infection and inflammation

Seminars in Nuclear Medicine

Volumn 42, Issue 4, 2012, Pages 261-266

  Palestro, Christopher J ^a,b   Love, Charito ^c  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b Northwell Health   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; TECHNETIUM 99M;

CHURG STRAUSS SYNDROME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; ENDOPROSTHESIS LOOSENING; FOOT DISEASE; GIANT CELL ARTERITIS; HUMAN; INFECTION; INFLAMMATION; ISOTOPE LABELING; LEUKOCYTE; MAGNETIC RESONANCE ANGIOGRAPHY; OSTEOMYELITIS; POLYARTERITIS NODOSA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROSTHESIS INFECTION; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; TOTAL HIP PROSTHESIS; TREATMENT RESPONSE; VASCULITIS; WEGENER GRANULOMATOSIS;

DIAGNOSTIC IMAGING; FLUORODEOXYGLUCOSE F18; HUMANS; INFECTION; INFLAMMATION; SENSITIVITY AND SPECIFICITY;

EID: 84861993735     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2012.04.007     Document Type: Review

References (39)

1. Love C, Tomas MB, Tronco GG, et al: FDG-PET of infection and inflammation. Radiographics 2005;25:1357-1368
2. Vos FJ, Bleeker-Rovers CP, Corstens FH, et al: FDG-PET for imaging of non-osseous infection and inflammation. Q J Nucl Med Mol Imaging 2006;50:121-130 (Pubitemid 44054877)
3. Love C, Marwin SE, Palestro CJ: Nuclear medicine and the infected joint replacement. Semin Nucl Med 2009;39:66-78
4. 18F-FDG-PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001;42:44-48
5. Chacko TK, Zhuang H, Stevenson K, et al: The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun 2002;23:851-855
6. Reinartz P, Mumme T, Hermanns B, et al: Radionuclide imaging of the painful hip arthroplasty: Positron-emission tomography versus triplephase bone scanning. J Bone Joint Surg Br 2005;87:465-470
7. Manthey N, Reinhard P, Moog F, et al: The use of [18 F] fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun 2002;23:645-653 (Pubitemid 34748004)
8. Stumpe KD, Nötzli HP, Zanetti M, et al: FDG-PET for differentiation of infection and aseptic loosening in total hip replacements: Comparison with conventional radiography and three-phase bone scintigraphy. Radiology 2004;231:333-341 (Pubitemid 38552886)
9. 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med 2004;45:1864-1871
10. Kwee TC, Kwee RM, Alavi A: FDG-PET for diagnosing prosthetic joint infection: Systematic review and metaanalysis. Eur J Nucl Med Mol Imaging 2008;35:2122-2132
11. Lipsky BA, Berendt AR, Deery HG, et al: Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39:885-910 (Pubitemid 39328144)
12. Palestro CJ, Love C: Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009;39:52-65
13. 18F-FDG-PET/CT. J Nucl Med 2005;46:444-449
14. Schwegler B, Stumpe KD, Weishaupt D, et al: Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG-PET or 99mTc-MOAB. J Intern Med 2008; 263:99-106 (Pubitemid 350243549)
15. Basu S, Chryssikos T, Houseni M, et al: Potential role of FDG-PET in the setting of diabetic neuro-osteoarthropathy: Can it differentiate uncomplicated Charcot's neuropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun 2007;28:465-472 (Pubitemid 46684196)
16. Höpfner S, Krolak C, Kessler S, et al: Preoperative imaging of Charcot neuroarthropathy in diabetic patients: Comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int 2004;25:890-895 (Pubitemid 40007587)
17. Nawaz A, Torigian DA, Siegelman ES, et al: Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol 2010;12:335-342
18. 18F-FDG-PET/CT replace WBC imaging in the diabetic foot? J Nucl Med 2011; 52:1012-1019
19. Palestro CJ: FDG and diabetic foot infections: The verdict is . . . J Nucl Med 2011;52:1009-1011
20. Zerizer I, Tan K, Khan S, et al: Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol 2010;73:504-509
21. Basu N, Watts R, Bajema I, et al: EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010;69:1744-1750
22. Genereau T, Lortholary O, Guillevin L, et al: Temporal 67gallium uptake is increased in temporal arteritis. Rheumatology 1999;38:709-713 (Pubitemid 29507385)
23. Chen CC, Kerr GS, Carter CS, et al. Lack of sensitivity of indium-111 mixed leukocyte scans for active disease in Takayasu's arteritis. J Rheumatol 1995;22:478-481
24. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, et al: Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004;116:50-53 (Pubitemid 38050027)
25. 18F- fluoro-2- deoxy-d-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004;43:241-242
26. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum 2006; 55:131-137
27. Both M, Ahmadi-Simab K, Reuter M, et al: MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008;67:1030-1033 (Pubitemid 351956669)
28. 18F- Fluorodeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiology 2011 Mar 8 [Epub ahead of print]
29. Blockmans D, Stroobants S, Maes A, et al: Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch. Am J Med 2000;108:246-249 (Pubitemid 30100617)
30. Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: A systematic review. Clin Rheumatol 2011;30:1265-1275
31. Rossleigh MA: Scintigraphic imaging in renal infections. Q J Nucl Med Mol Imaging 2009;53:72-77
32. 18F-FDG-PET in detecting metastatic infectious disease. J Nucl Med 2005;46:2014-2019
33. Simons KS, Pickkers P, Bleeker-Rovers CP, et al: F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med 2010;36:504-511
34. Yen RF, Chen YC, Wu YW, et al: Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: A preliminary report. Acad Radiol 2004;11:316-321
35. Lee BY, Newburg AB, Liebeskind DS, et al: FDG-PET findings in patients with suspected encephalitis. Clin Nucl Med 2004;29:620-625 (Pubitemid 40228165)
36. 18F-FET PET differentiation of ring-enhancing brain lesions. J Nucl Med 2006;47:776-782
37. Renard D, Dufour S, Collombier L, et al: Cerebral FDG-PET hypermetabolism in carcinomatous meningitis. Eur Neurol 2011;66:332-333
38. Mansouri MA, Iagaru A: F-18 FDG-PET/CT demonstration of lymphohistiocytic meningitis. Clin Nucl Med 2010;35:633-634
39. Bleeker-Rovers CP, de Sévaux RG, van Hamersvelt HW, et al: Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2003;41:E18-E21